Combined Haploidentical-Cord Blood Transplantation for Adults and Children
Interventional
Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
To assess the rate of engraftment with combined haploidentical-cord blood
60 days
Yes
Andrew Artz, M.D.
Principal Investigator
University of Chicago
United States: Institutional Review Board
14736B
NCT00943800
October 2006
June 2015
Name | Location |
---|---|
The University of Chicago | Chicago, Illinois 60637 |